Savant Capital, LLC Pfizer Inc Transaction History

Savant Capital, LLC

  • $11.7 Billion
  • Q3 2024

A detailed history of Savant Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Savant Capital, LLC holds 252,490 shares of PFE stock, worth $6.67 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
252,490
Previous 218,485 15.56%
Holding current value
$6.67 Million
Previous $6.11 Million 19.53%
% of portfolio
0.06%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$27.7 - $31.39 $941,938 - $1.07 Million
34,005 Added 15.56%
252,490 $7.31 Million
Q2 2024

Aug 05, 2024
SELL
$25.26 - $29.6 $349,876 - $409,989
-13,851 Reduced 5.96%
218,485 $6.11 Million
Q1 2024

May 03, 2024
BUY
$25.89 - $29.73 $489,709 - $562,342
18,915 Added 8.86%
232,336 $6.45 Million
Q4 2023

Feb 05, 2024
SELL
$26.13 - $33.94 $211,052 - $274,133
-8,077 Reduced 3.65%
213,421 $6.14 Million
Q3 2023

Nov 06, 2023
BUY
$32.09 - $37.51 $79,872 - $93,362
2,489 Added 1.14%
221,498 $7.35 Million
Q2 2023

Aug 04, 2023
BUY
$36.12 - $41.79 $2.75 Million - $3.19 Million
76,231 Added 53.39%
219,009 $8.03 Million
Q1 2023

May 02, 2023
SELL
$39.39 - $51.28 $1.5 Million - $1.95 Million
-38,068 Reduced 21.05%
142,778 $5.83 Million
Q4 2022

Feb 13, 2023
BUY
$41.75 - $54.5 $166,666 - $217,564
3,992 Added 2.26%
180,846 $9.27 Million
Q4 2022

Feb 06, 2023
BUY
$41.75 - $54.5 $3.37 Million - $4.39 Million
80,618 Added 83.77%
176,854 $9.07 Million
Q3 2022

Oct 28, 2022
BUY
$43.76 - $53.42 $75,223 - $91,828
1,719 Added 1.82%
96,236 $4.21 Million
Q2 2022

Jul 22, 2022
BUY
$46.53 - $55.17 $159,644 - $189,288
3,431 Added 3.77%
94,517 $4.96 Million
Q1 2022

May 05, 2022
BUY
$45.75 - $56.69 $37,926 - $46,996
829 Added 0.92%
91,086 $4.72 Million
Q4 2021

Feb 08, 2022
BUY
$41.32 - $61.25 $218,541 - $323,951
5,289 Added 6.22%
90,257 $5.33 Million
Q3 2021

Nov 12, 2021
BUY
$39.25 - $50.42 $402,940 - $517,611
10,266 Added 13.74%
84,968 $3.65 Million
Q2 2021

Aug 04, 2021
BUY
$35.91 - $40.68 $286,489 - $324,545
7,978 Added 11.96%
74,702 $2.93 Million
Q1 2021

May 04, 2021
BUY
$33.49 - $37.77 $7,267 - $8,196
217 Added 0.33%
66,724 $2.42 Million
Q4 2020

Feb 03, 2021
SELL
$33.47 - $42.56 $41,000 - $52,136
-1,225 Reduced 1.81%
66,507 $2.45 Million
Q3 2020

Nov 04, 2020
SELL
$31.75 - $37.25 $21,526 - $25,255
-678 Reduced 0.99%
67,732 $2.49 Million
Q2 2020

Aug 11, 2020
SELL
$30.12 - $36.54 $129,154 - $156,683
-4,288 Reduced 5.9%
68,410 $2.24 Million
Q1 2020

Apr 30, 2020
BUY
$27.03 - $38.62 $324,846 - $464,135
12,018 Added 19.81%
72,698 $2.37 Million
Q4 2019

Jan 31, 2020
BUY
$32.92 - $37.36 $30,846 - $35,006
937 Added 1.57%
60,680 $2.38 Million
Q3 2019

Nov 12, 2019
BUY
$32.49 - $42.13 $45,258 - $58,687
1,393 Added 2.39%
59,743 $2.15 Million
Q2 2019

Aug 06, 2019
BUY
$36.98 - $41.52 $4,363 - $4,899
118 Added 0.2%
58,350 $2.53 Million
Q1 2019

May 02, 2019
BUY
$37.5 - $41.2 $17,212 - $18,910
459 Added 0.79%
58,232 $2.47 Million
Q4 2018

Feb 05, 2019
SELL
$38.47 - $43.86 $34,276 - $39,079
-891 Reduced 1.52%
57,773 $2.52 Million
Q3 2018

Oct 23, 2018
BUY
$34.47 - $41.81 $5,239 - $6,355
152 Added 0.26%
58,664 $2.59 Million
Q2 2018

Aug 07, 2018
BUY
$32.98 - $35.16 $43,896 - $46,797
1,331 Added 2.33%
58,512 $2.12 Million
Q1 2018

Apr 27, 2018
BUY
$31.91 - $37.02 $71,478 - $82,924
2,240 Added 4.08%
57,181 $2.03 Million
Q4 2017

Jan 31, 2018
BUY
$33.26 - $35.29 $76,498 - $81,167
2,300 Added 4.37%
54,941 $1.99 Million
Q3 2017

Oct 31, 2017
BUY
$31.0 - $34.15 $1.63 Million - $1.8 Million
52,641
52,641 $1.88 Million

Others Institutions Holding PFE

# of Institutions
3,261
Shares Held
3.62B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email